CBI-1214
/ Cartography Biosci
- LARVOL DELTA
Home
Next
Prev
1 to 1
Of
1
Go to page
1
December 18, 2025
Cartography Receives FDA Investigational New Drug (IND) Approval and Fast Track Designation for Lead Program CBI-1214 for Colorectal Cancer
(PharmiWeb)
- "Cartography anticipates initiating its Phase I clinical trial in the first quarter of 2026."
Fast track • IND • New P1 trial • Colorectal Cancer
1 to 1
Of
1
Go to page
1